OncoVAX uses Monoclonal antibodies which represent one of the most significant advances in cancer treatment over the past 20 years.
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with Twitter
I don't have a Facebook or a Twitter account
Your new post is loading...
Your new post is loading...
|
OncoVax uses mabs.
OncoVAX® is an autologous cancer vaccine manufactured with a patented process to leverage a patient’s own tumor cells to launch a potent and customized immune response against residual cancer cells that may reside in the body after surgery. Killing these residual cells is key to preventing the recurrence of the cancer.